Archive for 2016

Home Archive for 2016

Moving Forward

17^th June2016 06:10:00 PM

Up until now, I've used this blog for a class I was taking last semester: IEOR 190G - Mobile Wireless Networking & Patent Engineering Blog. Now that class is over and I've graduated I've decided to continue this blog and keep on writing about patents, innovation, and biotech. That said, I think it's appropriate to write about a couple

Last Week: Semester Recap

01^th May2016 01:54:00 AM

By Unknown with 0 Comments

IEOR 190G has been very supplemental to my undergraduate career and professional interests. I'm a Molecular Biology and Legal Studies double major who was introduced to patents in the context of economic access to medicines. Throughout this semester I've actually been working on a senior thesis on "Patenting Hematopoietic Stem Cell Technologies: Implications for Follow-On Innovation". This project

Last Week: Social Media Learning

01^th May2016 12:23:00 AM

By Unknown with 0 Comments

Throughout this course we have used social media as the basis of our assignments and learning. Rather than pure lecture, we learned from each other through blog posts, comments, youtube videos, and tweets. This is the first student-to-student interaction has been central to a course for me, let alone social media. I think that this is a very

Smartphone Litigation #2: Microsoft Corp v. Motorola

25^th April2016 04:04:00 PM

By Unknown with 0 Comments

Microsoft sued Motorola for violating a licensing agreement (reasonable and non-discriminatory licensing agreement). Microsoft was a third party beneficiary of this agreement. While this litigation was going on in the U.S., Motorola claimed that Microsoft infringed upon its patents in Germany. A German district court ended up granting Motorola an injunction against Microsoft's production of products that infringed

Smartphone Litigation #1: WARF (Wisconsin Alumni Research Foundation) v. Apple Inc

25^th April2016 04:01:00 PM

By Unknown with 0 Comments

WARF sued Apple for patent infringement on microprocessor technology patent for $400M. The patent protected claims regarding processor chip design that improved microprocessor performance. WARF claimed that this patent was infringed upon by Apple's A7 processors for its iphone 5s and ipad. A jury in Madison found that Apple did indeed infringe upon the patent, determining that it

Silly Patent #2: Life Expectancy Timepiece

10^th April2016 07:28:00 PM

By Unknown with 1 Comments

Silly Patent #2: Life Expectancy Timepiece Image

US5031161, or "Life Expectancy Timepiece" is a patent on a backwards counting watch that predicts how much time you have left... alive. So I guess with this you don't have to live every day like it's your last because you know exactly how many you have left and how to ration out your time. This invention as a

Silly Patent #1: Banana Protective Device

10^th April2016 07:20:00 PM

By Unknown with 0 Comments

Silly Patent #1: Banana Protective Device Image

When we think of patents, we think of inventions like the latest mobile phone feature or a groundbreaking diagnostic test for HIV. By the nature of intellectual property law, patents intend to incentivize innovation that would otherwise be unattractive to pursue. Yet not-so-innovative products are awarded patents. One silly patent that I found is US6612449B1, or a "Banana

Obviousness Case #2: In re Glatt Air Techniques, Inc.

10^th April2016 07:01:00 PM

By Unknown with 0 Comments

Glatt's invention applies coats to particles such as pharmaceutical ingredients. This case involves the Federal Circuit reversing the U.S. Board of Patent Appeals and Interferences decision that claim 5 of US5236503 was obvious. Claim 5 follows as: In a fluidized bed coater having a product container opening upwardly into an expansion chamber and downwardly into a lower plenum

Obviousness Case #1: Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories Ltd.

04^th April2016 01:46:00 PM

By Unknown with 0 Comments

Background: This case involves Caraco's alleged infringement of one of Novo Nordisk's patents on Prandin, and anti-diabetic drug. Caraco filed for an Abbreviated New Drug Application (ANDA) in 2005, in regards to a Prandin generic. In its ANDA, Caraco notes that it would not be infringing upon Novo Nordisk's patent on the grounds of invalidity and unenforceability. Novo

Unicorn Analysis #2: Stemcentrx

28^th March2016 03:11:00 PM

By Unknown with 0 Comments

Stemcentrx is a biotech unicorn that aims to create novel cancer therapeutics by targeting cancer stem cells. Valuation: $5 Billion Patents: 23 Pending Patents: 2 Trademarks: 2 Competitors: Juno Therapeutics, Oncomed Pharmaceuticals, AbbVie Inc Most of Stemcentrx's patents involve anti-DLL3 antibodies. Some examples follow: US9089617B2: Anti-DLL3 antibody drug conjugates US9090683: Methods of Detection, Diagnosis, and Monitoring Using Anti-DLL3 Antibodies US9155803: ANTI-DLL3

Unicorn Analysis #1: Blue Apron

28^th March2016 02:56:00 PM

By Unknown with 0 Comments

Blue Apron is a Unicorn that delivers ingredients and recipes for various meals to individuals seeking to learn more about cooking, and master gourmet techniques. One distinguishing factor between Blue Apron and its competitors is its delivery of wine, and wine pairing suggestions. Estimated Valuation: $2 Billion # of patents owned: 0 Competitors: HelloFresh, Plated, Instacart As an

Patent Claim Analysis: Teva v. Sandoz

27^th March2016 07:01:00 PM

By Unknown with 0 Comments

Patent Claim Analysis: Teva v. Sandoz Image

Today I am going to discuss patent claims involved in the case Supreme Court case Teva Pharmaceuticals USA, Inc. v. Sandoz Inc. Case Background: Teva sued Sandoz for patent infringement of Copaxone, a drug used to treat the neurological disorder Multiple Sclerosis. In defense, Sandoz claimed that Teva's patent claims were indefinite in that the term "molecular weight" had

Patent Claim Analysis: Nuclear Factors Associated with Transcriptional Regulation

27^th March2016 06:19:00 PM

By Unknown with 0 Comments

Patent Claim Analysis: Nuclear Factors Associated with Transcriptional Regulation Image

Today I am going to discuss the key patent claims involved in Ariad Pharmaceuticals et al. v. Eli Lilly and Company. Case Background: In this case, Ariad Pharma accused Eli Lilly of infringing on a patent regarding to Eli Lilly's osteoporosis medication and sepsis treatment. Though the lower court ruled in favor of Ariad, the appellate court reversed this

Patenting Dolly the Sheep: In Re Roslin

05^th March2016 02:28:00 PM

By Unknown with 1 Comments

Patenting Dolly the Sheep: In Re Roslin Image

In 1996 Ian Wilmut and Keith Campbell from Roslin Institute pushed what was once thought of as science fiction into the realm of reality: mammalian cloning. From a scientific perspective, Dolly is undoubtedly a hallmark biotechnological innovation. However, Dolly the sheep was not awarded patent protection. The patent system is a legal mechanism that exists to incentivize

Subscribe to: Posts ( Atom )

Related

Related

Related

Related